trending Market Intelligence /marketintelligence/en/news-insights/trending/izgudht_zx-er_xe-sg9mw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Report: Nestle, Unilever, others vying for GSK's Horlicks unit

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Report: Nestle, Unilever, others vying for GSK's Horlicks unit

Food giants Nestlé SA, Kraft Heinz Co. and Unilever NV are interested in acquiring GlaxoSmithKline PLC's health nutrition unit, Reuters reported March 27, citing people familiar with the matter.

The unnamed sources told the news outlet that a sale of the Horlicks business might garner more than $4 billion.

The main asset in the deal is GSK's 72.5% stake in its Indian division GlaxoSmithKline Consumer Healthcare.

GSK reportedly started a strategic review of Horlicks, and some of its smaller products, after agreeing to pay $13 billion for Novartis AG's stake in the companies' consumer healthcare joint venture.

Nestle has expressed interest in the GSK business on several occasions, the news outlet reported. Nestle or Unilever could purchase the business through their respective local Indian subsidiaries, Nestle India and Hindustan Unilever.

According to Reuters, Coca-Cola Co., PepsiCo Inc., Suntory, Mondelez International Inc. and JAB are also among potential suitors of the unit.